Search results
Results from the WOW.Com Content Network
Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. [10] [11] This use of drug delivery systems was first proposed by Gregory Gregoriadis in 1974, who outlined liposomes as a drug delivery system for chemotherapy. [12]
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential ...
In special cases, nanotechnology can help reduce costs for complicated problems. But in most cases, the traditional method for construction remains more cost-efficient. [11] With the improvement of manufacturing technologies, the costs of applying nanotechnology into construction have been decreasing over time and are expected to decrease more ...
Chamberland et al studied the use of anti-TNF conjugated gold nanorods (AuNRs) ex vivo in rat tail joints to reduce the effect of rheumatoid arthritis. They observed the effects of the drug delivery system via PAT technology. The properties of the AuNRs found to be the most efficient had measurements of 45 x 15 nm with an absorption peak of 660 nm.
The use of CNTs in drug delivery and biosensing technology has the potential to revolutionalize medicine. Functionalization of single-walled nanotubes (SWNTs) has proven to enhance solubility and allow for efficient tumor targeting/drug delivery. It prevents SWNTs from being cytotoxic and altering the function of immune cells.
A 2016 study published in the American Journal of Managed Care estimated that over-the-counter statin access could prevent over 250,000 major coronary events over 10 years.
Protein nanotechnology is a burgeoning field of research that integrates the diverse physicochemical properties of proteins with nanoscale technology. This field assimilated into pharmaceutical research to give rise to a new classification of nanoparticles termed protein (or protein-based) nanoparticles (PNPs).
Karyn Hascal, The Healing Place’s president and CEO, said she would never allow Suboxone in her treatment program because her 12-step curriculum is “a drug-free model. There’s kind of a conflict between drug-free and Suboxone.” For policymakers, denying addicts the best scientifically proven treatment carries no political cost.